Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 233

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

Open access
Ageno, Walter, Riva, Nicoletta, Schulman, Sam, Beyer-Westendorf, Jan, Bang, Soo Mee, Senzolo, Marco, Grandone, Elvira, Pasca, Samantha, Di Minno, Matteo Nicola Dario, Duce, Rita, Malato, Alessandra, Santoro, Rita, Poli, Daniela, Verhamme, Peter, Martinelli, Ida, Kamphuisen, Pieter, Oh, Doyeun, D’Amico, Elbio, Becattini, Cecilia, De Stefano, Valerio, Vidili, Gianpaolo, Vaccarino, Antonella, Nardo, Barbara, Di Nisio, Marcello, Dentali, Francesco · 2015 · JAMA Internal Medicine

Abstract

IMPORTANCE: Little information is available on the long-term clinical outcome of patients with splanchnic vein thrombosis (SVT). OBJECTIVE: To assess the incidence rates of bleeding, thrombotic events, and mortality in a large international cohort of patients with SVT. DESIGN, SETTING, AND PARTICIPANTS: A prospective cohort study was conducted beginning May 2, 2008, and completed January 30, 2014, at hospital-based centers specialized in the management of thromboembolic disorders; a 2-year follow-up period was completed January 30, 2014, and data analysis was conducted from July 1, 2014, to February 28, 2015. Participants included 604 consecutive patients with objectively diagnosed SVT; there were no exclusion critieria. Information was gathered on baseline characteristics, risk factors, and antithrombotic treatment. Clinical outcomes during the follow-up period were documented and reviewed by a central adjudication committee. MAIN OUTCOMES AND MEASURES: Major bleeding, defined according to the International Society on Thrombosis and Hemostasis; bleeding requiring hospitalization; thrombotic events, including venous and arterial thrombosis; and all-cause mortality. RESULTS: Of the 604 patients (median age, 54 years; 62.6% males), 21 (3.5%) did not complete follow-up. The most common risk factors for SVT were liver cirrhosis (167 of 600 patients [27.8%]) and solid cancer (136 of 600 [22.7%]); the most common sites of thrombosis were the portal vein (465 of 604 [77.0%]) and the mesenteric veins (266 of 604 [44.0%]). Anticoagulation was administered to 465 patients in the entire cohort (77.0%) with a mean duration of 13.9 months; 175 of the anticoagulant group (37.6%) received parenteral treatment only, and 290 patients (62.4%) were receiving vitamin K antagonists. The incidence rates (reported with 95% CIs) were 3.8 per 100 patient-years (2.7-5.2) for major bleeding, 7.3 per 100 patient-years (5.8-9.3) for thrombotic events, and 10.3 per 100 patient-years (8.5-12.5) for all-cause mortality. During anticoagulant treatment, these rates were 3.9 per 100 patient-years (2.6-6.0) for major bleeding and 5.6 per 100 patient-years (3.9-8.0) for thrombotic events. After treatment discontinuation, rates were 1.0 per 100 patient-years (0.3-4.2) and 10.5 per 100 patient-years (6.8-16.3), respectively. The highest rates of major bleeding and thrombotic events during the whole study period were observed in patients with cirrhosis (10.0 per 100 patient-years [6.6-15.1] and 11.3 per 100 patient-years [7.7-16.8], respectively); the lowest rates were in patients with SVT secondary to transient risk factors (0.5 per 100 patient-years [0.1-3.7] and 3.2 per 100 patient-years [1.4-7.0], respectively). CONCLUSIONS AND RELEVANCE: Most patients with SVT have a substantial long-term risk of thrombotic events. In patients with cirrhosis, this risk must be balanced against a similarly high risk of major bleeding. Anticoagulant treatment appears to be safe and effective in most patients with SVT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2015.3184

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 233

Metadata

Authors
Ageno, W., Riva, N., Schulman, S., Beyer-Westendorf, J., Bang, S. M., Senzolo, M., Grandone, E., Pasca, S., Di Minno, M. N. D., Duce, R., Malato, A., Santoro, R., Poli, D., Verhamme, P., Martinelli, I., Kamphuisen, P., Oh, D., D’Amico, E., Becattini, C., De Stefano, V., Vidili, G., Vaccarino, A., Nardo, B., Di Nisio, M., & Dentali, F.
Venue
JAMA Internal Medicine
Published
2015-09-01
Volume
175
Issue
9
Pages
1474
ISSN
2168-6106 (ISSN-L)
OpenAlex
W1861743845
Cited by
233
References
4
FWCI
23.37
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. https://app.cochat.ai/papers/10.1001/jamainternmed.2015.3184
The paper
Ageno, W., Riva, N., Schulman, S., Beyer-Westendorf, J., Bang, S. M., Senzolo, M., Grandone, E., Pasca, S., Di Minno, M. N. D., Duce, R., Malato, A., Santoro, R., Poli, D., Verhamme, P., Martinelli, I., Kamphuisen, P., Oh, D., D’Amico, E., Becattini, C., . . . Dentali, F. (2015). Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2015.3184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.